If the new work is replicated and confirmed, it may allow for faster diagnosis and tracking of myriad psychiatric and neurological conditions. Among them: chronic depression. Study co-author Grigori Enikolopov, an associate professor of molecular biology at Cold Spring Harbor Laboratory in Long Island, N.Y., showed last year that antidepressants lead to new nervous system cells, raising questions about the role these cells play in the causation of the ailment.
"Although we are only just beginning to test applications, it is clear that this biomarker may have promise in identifying cell proliferation in the brain, which can be a sign of cancer," Enikolopov says. "In other patients, it could show us how neurogenesis is related to the course of diseases such as depression, bipolar disorder, Alzheimer's, Parkinson's, MS, and post-traumatic stress disorder."